Delivery Order SPE2DB22D3004-SPE2DB25FRF31
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,530.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 26, 2025, utilizes firm fixed pricing and carries an ultimate completion date of September 17, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in the...
- The Defense Logistics Agency awarded a delivery order valued at $2,064.22 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on September 23, 2025, with an ultimate completion date of October 15, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $22,761.00 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents one of multiple pharmaceutical procurement...
- The Defense Logistics Agency has awarded a delivery order valued at $30,963.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 5, 2025, carries a firm fixed price and has an ultimate completion date of August 26, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, reflecting the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance of this delivery order will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.33 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The order, issued on July 29, 2025, is scheduled for completion by August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the established pharmaceutical distributor. This delivery order...
- The Defense Logistics Agency awarded a $94,770.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varivax vaccine with diluents. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,032.11. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,064.22 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRF31Delivery Order
The Defense Logistics Agency has awarded a delivery order valued at $2,064.22 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-competitive delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting military and federal healthcare supply requirements. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 and extends through December 2026. As a comprehensive global pharmaceutical support vehicle, the SPE2DX contract enables AmerisourceBergen to deliver a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The parent IDC reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/27/25 |